MAPT and Alzheimer disease: One recent study that linked TXNIP to AD pathology showed that inhibiting TXNIP expression in SH-SY5Y cells and AD model mice using a pharmaceutical agent directly inhibited the phosphorylation of the microtubule associated protein tau (Melone et al., 2018).